Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

How do ICUs worldwide manage breathing tubes? a massive study investigates

NCT ID NCT07769021

Knowledge-focused Sponsor: Royal College of Surgeons, Ireland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 17, 2026 · Last updated Aug 18, 2026 · Updated 1 time

Summary

This international study will track how tracheostomies—breathing tubes placed in the windpipe—are inserted, managed, and removed in adult intensive care units (ICUs) across the globe. By observing the care of thousands of patients, researchers hope to uncover variations in practice and identify what leads to better outcomes, such as successful removal of the tube and improved recovery. The findings could help standardize care and enhance safety for critically ill patients who need this procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
This study could identify best practices for tracheostomy care, potentially leading to guidelines that improve recovery and reduce complications for ICU patients worldwide.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may vary across different ICUs and may not apply to all settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,500 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Mar 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patients aged 18 years and older admitted in the intensive care unit after commencement of the enrolment period, and that are in receipt of invasive ventilator support, will be screened daily until ICU discharge or death. Those that undergo tracheostomy insertion during critical care admission will be included in the study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Greater than 18 years of age * Tracheostomy insertion during critical care admission Exclusion Criteria: * Tracheostomy prior to critical care admission * Elective tracheostomy insertion for head and neck pathology * Tracheostomy insertion for emergency surgical management of airway obstruction * Mini tracheostomy insertion only

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intensive care (ICU) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intensive care (ICU) Tracheostomy decannulation Tracheostomy patients

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites in 8 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beaumont Hospital

    Dublin, Ireland

  • Beth Israel Medical Centre

    Boston, Massachusetts, 02215, United States

  • Galway University Hospital

    Galway, Ireland

  • Manchester University Hospital

    Manchester, United Kingdom

  • Mater Misericordiae University Hospital Dublin

    Dublin, Ireland

  • Nereu Ramos Hospital

    Florianópolis, Brazil

  • Ospedale Policlinico San Martino Genoa

    Genova, Italy

  • Tata Memorial Hospital

    Mumbai, India

  • Toronto General Hospital

    Toronto, Canada

  • University Hospital San Luigi Gonzaga Turin

    Torino, Italy

  • University Hospital of Lausanne

    Lausanne, Switzerland

  • University of Michigan Health Ann Arbor

    Ann Arbor, Michigan, 48109, United States

  • University of Naples Frederico II

    Naples, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.